USA – Biogen is planning to lay off over 1000 employees following the disappointing launch of its Alzheimer’s therapy Aduhelm (aducanumab), according to STAT News. According to STAT News, Biogen…
Read MoreBiogen mulls massive layoffs following disappointing Aduhelm rollout: Report
